A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

NCT00385970 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Tegafur-uracil (UFT)
DRUG: Calcium folinate (LV)
DRUG: Krestin (PSK)

Sponsor

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group